Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1981 2
1982 7
1983 5
1984 16
1985 17
1986 29
1987 30
1988 31
1989 37
1990 39
1991 37
1992 34
1993 32
1994 35
1995 19
1996 35
1997 24
1998 29
1999 33
2000 44
2001 39
2002 33
2003 37
2004 38
2005 39
2006 59
2007 67
2008 59
2009 73
2010 79
2011 78
2012 67
2013 82
2014 65
2015 60
2016 62
2017 49
2018 57
2019 62
2020 60
2021 48
2022 35
2023 27
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

1,660 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.
Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A, Nordbeck P, Olivotto I, Pietilä-Effati P, Namdar M. Pieroni M, et al. J Am Coll Cardiol. 2021 Feb 23;77(7):922-936. doi: 10.1016/j.jacc.2020.12.024. J Am Coll Cardiol. 2021. PMID: 33602475 Free article. Review.
Fabry Disease: The Current Treatment Landscape.
Lenders M, Brand E. Lenders M, et al. Drugs. 2021 Apr;81(6):635-645. doi: 10.1007/s40265-021-01486-1. Epub 2021 Mar 15. Drugs. 2021. PMID: 33721270 Free PMC article. Review.
Migalastat: A Review in Fabry Disease.
McCafferty EH, Scott LJ. McCafferty EH, et al. Drugs. 2019 Apr;79(5):543-554. doi: 10.1007/s40265-019-01090-4. Drugs. 2019. PMID: 30875019 Free PMC article. Review.
Cipaglucosidase Alfa: First Approval.
Blair HA. Blair HA. Drugs. 2023 Jun;83(8):739-745. doi: 10.1007/s40265-023-01886-5. Drugs. 2023. PMID: 37184753 Free PMC article. Review.
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Benjamin ER, Della Valle MC, Wu X, Katz E, Pruthi F, Bond S, Bronfin B, Williams H, Yu J, Bichet DG, Germain DP, Giugliani R, Hughes D, Schiffmann R, Wilcox WR, Desnick RJ, Kirk J, Barth J, Barlow C, Valenzano KJ, Castelli J, Lockhart DJ. Benjamin ER, et al. Genet Med. 2017 Apr;19(4):430-438. doi: 10.1038/gim.2016.122. Epub 2016 Sep 22. Genet Med. 2017. PMID: 27657681 Free PMC article.
Chaperone Therapy in Fabry Disease.
Weidemann F, Jovanovic A, Herrmann K, Vardarli I. Weidemann F, et al. Int J Mol Sci. 2022 Feb 8;23(3):1887. doi: 10.3390/ijms23031887. Int J Mol Sci. 2022. PMID: 35163813 Free PMC article. Review.
Substrate reduction therapy.
Platt FM, Jeyakumar M. Platt FM, et al. Acta Paediatr. 2008 Apr;97(457):88-93. doi: 10.1111/j.1651-2227.2008.00656.x. Acta Paediatr. 2008. PMID: 18339196 Review.
Chemical synthetic biology.
Chiarabelli C, Luisi PL. Chiarabelli C, et al. Sci Prog. 2014;97(Pt 1):48-61. doi: 10.3184/003685014X13921159313230. Sci Prog. 2014. PMID: 24800469 Free PMC article. Review.
1,660 results